132 related articles for article (PubMed ID: 25434100)
21. Different anticancer effects of Saxifragifolin A on estrogen receptor-positive and estrogen receptor-negative breast cancer cells.
Kim KH; Kim JY; Kwak JH; Pyo S
Phytomedicine; 2015 Aug; 22(9):820-8. PubMed ID: 26220629
[TBL] [Abstract][Full Text] [Related]
22. MT(1) melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells.
Yuan L; Collins AR; Dai J; Dubocovich ML; Hill SM
Mol Cell Endocrinol; 2002 Jun; 192(1-2):147-56. PubMed ID: 12088876
[TBL] [Abstract][Full Text] [Related]
23. Effects of xenoestrogenic environmental pollutants on the proliferation of a human breast cancer cell line (MCF-7).
Blom A; Ekman E; Johannisson A; Norrgren L; Pesonen M
Arch Environ Contam Toxicol; 1998 Apr; 34(3):306-10. PubMed ID: 9504980
[TBL] [Abstract][Full Text] [Related]
24. Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.
Treeck O; Lattrich C; Springwald A; Ortmann O
Breast Cancer Res Treat; 2010 Apr; 120(3):557-65. PubMed ID: 19434490
[TBL] [Abstract][Full Text] [Related]
25. Differential expression of estrogen receptor alpha (ERalpha) protein in MCF-7 breast cancer cells chronically exposed to TCDD.
Marquez-Bravo LG; Gierthy JF
J Cell Biochem; 2008 Feb; 103(2):636-47. PubMed ID: 17960587
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of skeletal metastasis by ectopic ERalpha expression in ERalpha-negative human breast cancer cell lines.
Bandyopadhyay A; Wang L; Chin SH; Sun LZ
Neoplasia; 2007 Feb; 9(2):113-8. PubMed ID: 17356707
[TBL] [Abstract][Full Text] [Related]
27. Anticancer effect of metformin on estrogen receptor-positive and tamoxifen-resistant breast cancer cell lines.
Kim J; Lee J; Jang SY; Kim C; Choi Y; Kim A
Oncol Rep; 2016 May; 35(5):2553-60. PubMed ID: 26986571
[TBL] [Abstract][Full Text] [Related]
28. Di-(2-ethylhexyl)-phthalate induces apoptosis via the PPARγ/PTEN/AKT pathway in differentiated human embryonic stem cells.
Fang H; Fang W; Cao H; Luo S; Cong J; Liu S; Pan F; Jia X
Food Chem Toxicol; 2019 Sep; 131():110552. PubMed ID: 31163220
[TBL] [Abstract][Full Text] [Related]
29. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
Pink JJ; Jordan VC
Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
[TBL] [Abstract][Full Text] [Related]
30. Chemical activity-based environmental risk analysis of the plasticizer di-ethylhexyl phthalate and its main metabolite mono-ethylhexyl phthalate.
Gobas FAPC; Otton SV; Tupper-Ring LF; Crawford MA; Clark KE; Ikonomou MG
Environ Toxicol Chem; 2017 Jun; 36(6):1483-1492. PubMed ID: 27859543
[TBL] [Abstract][Full Text] [Related]
31. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
Lykkesfeldt AE; Madsen MW; Briand P
Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
[TBL] [Abstract][Full Text] [Related]
32. Triptolide inhibits human breast cancer MCF-7 cell growth via downregulation of the ERα-mediated signaling pathway.
Li H; Pan GF; Jiang ZZ; Yang J; Sun LX; Zhang LY
Acta Pharmacol Sin; 2015 May; 36(5):606-13. PubMed ID: 25864647
[TBL] [Abstract][Full Text] [Related]
33. Di(2-ethylhexyl) phthalate-induced toxicity and peroxisome proliferator-activated receptor alpha: a review.
Ito Y; Kamijima M; Nakajima T
Environ Health Prev Med; 2019 Jul; 24(1):47. PubMed ID: 31279339
[TBL] [Abstract][Full Text] [Related]
34. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
[TBL] [Abstract][Full Text] [Related]
35. Nordihydroguaiaretic acid (NDGA), an inhibitor of the HER2 and IGF-1 receptor tyrosine kinases, blocks the growth of HER2-overexpressing human breast cancer cells.
Zavodovskaya M; Campbell MJ; Maddux BA; Shiry L; Allan G; Hodges L; Kushner P; Kerner JA; Youngren JF; Goldfine ID
J Cell Biochem; 2008 Feb; 103(2):624-35. PubMed ID: 17562544
[TBL] [Abstract][Full Text] [Related]
36. Breast cancer-derived M543V mutation in helix 12 of estrogen receptor alpha inverts response to estrogen and SERMs.
Nichols M; Cheng P; Liu Y; Kanterewicz B; Hershberger PA; McCarty KS
Breast Cancer Res Treat; 2010 Apr; 120(3):761-8. PubMed ID: 19526339
[TBL] [Abstract][Full Text] [Related]
37. Expression and regulation of Cyr61 in human breast cancer cell lines.
Tsai MS; Bogart DF; Li P; Mehmi I; Lupu R
Oncogene; 2002 Jan; 21(6):964-73. PubMed ID: 11840342
[TBL] [Abstract][Full Text] [Related]
38. AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.
Grabinski N; Möllmann K; Milde-Langosch K; Müller V; Schumacher U; Brandt B; Pantel K; Jücker M
Cell Signal; 2014 May; 26(5):1021-9. PubMed ID: 24463007
[TBL] [Abstract][Full Text] [Related]
39. Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells.
Perry RR; Kang Y; Greaves B
Ann Surg Oncol; 1995 May; 2(3):238-45. PubMed ID: 7641021
[TBL] [Abstract][Full Text] [Related]
40. Anticancer effect of acid ceramidase inhibitor ceranib-2 in human breast cancer cell lines MCF-7, MDA MB-231 by the activation of SAPK/JNK, p38 MAPK apoptotic pathways, inhibition of the Akt pathway, downregulation of ERα.
Vethakanraj HS; Sesurajan BP; Padmanaban VP; Jayaprakasam M; Murali S; Sekar AK
Anticancer Drugs; 2018 Jan; 29(1):50-60. PubMed ID: 29023248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
